Medicus Pharma Current Valuation vs. Retained Earnings
| MDCX Stock | USD 2.75 0.05 1.79% |
For Medicus Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medicus Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medicus Pharma Ltd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medicus Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medicus Pharma Ltd over time as well as its relative position and ranking within its peers.
Medicus |
Medicus Pharma Retained Earnings vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medicus Pharma's current stock value. Our valuation model uses many indicators to compare Medicus Pharma value to that of its competitors to determine the firm's financial worth. Medicus Pharma Ltd is rated top company in current valuation category among its peers. It also is considered to be number one stock in retained earnings category among its peers . Medicus Pharma reported Retained Earnings of (19.18 Million) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicus Pharma's earnings, one of the primary drivers of an investment's value.Medicus Current Valuation vs. Competition
Medicus Pharma Ltd is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Other industry is now estimated at about 5.2 Billion. Medicus Pharma maintains roughly 27.87 Million in current valuation contributing less than 1% to all equities under Other industry.
Medicus Retained Earnings vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Medicus Pharma |
| = | 27.87 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Medicus Pharma |
| = | (19.18 M) |
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Medicus Retained Earnings Comparison
Medicus Pharma is currently under evaluation in retained earnings category among its peers.
Medicus Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Medicus Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medicus Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Medicus Pharma's change in net profit over the period of time. It can combine multiple indicators of Medicus Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -3 M | -2.9 M | |
| Net Loss | -6.8 M | -6.4 M | |
| Income Before Tax | -6.8 M | -6.4 M | |
| Net Loss | -159.7 K | -167.7 K | |
| Net Loss | -6.8 M | -6.4 M | |
| Net Interest Income | -1.2 M | -1.2 M | |
| Total Other Income Expense Net | -2.6 M | -2.5 M | |
| Change To Netincome | 86.2 K | 90.6 K |
Medicus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medicus Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medicus Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medicus Pharma's important profitability drivers and their relationship over time.
Use Medicus Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medicus Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicus Pharma will appreciate offsetting losses from the drop in the long position's value.Medicus Pharma Pair Trading
Medicus Pharma Ltd Pair Trading Analysis
The ability to find closely correlated positions to Medicus Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medicus Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medicus Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medicus Pharma Ltd to buy it.
The correlation of Medicus Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medicus Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medicus Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medicus Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Medicus Pharma position
In addition to having Medicus Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medicus OTC BB Equity Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.